Various hormonal conditions and imbalances can significantly increase the risk of developing type 2 diabetes by interfering with normal glucose metabolism and insulin function.

Pancreatic Cell Cilia Wiggle to Control Insulin Release Tiny hairlike structures on pancreatic cells have long been considered static sensors. Now, researchers say they move and help regulate insulin ...

Scientists are developing new ways to administer insulin as a diabetes treatment. New research suggests cells can be genetically engineered to release insulin when rock music is played – and ...

A new study discusses the impact of several human viruses on blood-brain barrier function and insulin sensitivity.

Glucagon-like peptide-1 receptor agonists, like liraglutide, enhance insulin release and reduce appetite, aiding in weight loss.

Semaglutide offers a multifaceted approach to type 2 diabetes treatment, enhancing insulin release and reducing blood sugar through glucagon suppression.

Can it go into remission? Yes, usually. People with prediabetes experience impaired insulin release and insulin resistance, explains Priya Jaisinghani, M.D., an endocrinologist at NYU Langone Health.

The GLP-1 receptor in cell membranes binds hormones released after meals, stimulating the production of insulin. Drugs that activate the GLP-1 receptor, then, also promote insulin release.